Report

src

Global Human Milk Oligosaccharides Market Size, Share & Recession Impact Analysis, By Product Type (2’FL, 3’FL, 3’SL and 6’SL), By Application (Infant Formula, Functional Food & Beverage and Food Supplements), By Distribution Channel (Hypermarkets & Supermarkets, Drug Store or Pharmacy, Mass Merchandiser, Departmental Stores, Mono-brand Stores, Specialty Stores and Online Sales Channel), and Regional Forecasts, 2023-2030

Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.
The global human milk oligosaccharides market size was valued at USD 194.5 million in 2022. The market is projected to grow from USD 194.5 million in 2022 to USD 800.6 million by 2030, exhibiting a CAGR of 22.40% during the forecast period.
 
The utilisation of various nutritional items used as food or dietary supplements has expanded due to the surge in demand for HMOs. The availability of new technologies, such as enzymatic trans-glycosylation, which is used to artificially synthesise the HMOs, is one of the key reasons and market trends that propels the growth of the human milk oligosaccharides (HMO) market. The market for human milk oligosaccharides (HMO) is anticipated to generate significant revenue during the forecast period due to an expansion of its application potential in infant formula and functional foods and beverages, rapid technological advancement in the product line, an increase in consumer awareness of health issues, and the quick growth of the dairy industry.
 
RECESSION IMPACT

The recession will have a significant effect on the market for human milk oligosaccharides. Consumers typically cut back on their purchases of speciality infant formulae that contain HMOs during a recession. This can result in less demand for HMOs and slower market expansion. Moreover, consumers may switch to less expensive infant formula products that do not contain HMOs in an effort to save money. This may result in a further decline in the market's demand for HMOs. Due to decreased manufacturing, transportation, and distribution, a recession may generate supply chain disruptions. This may alter the market's supply of HMOs, driving up costs and decreasing demand.
 
DRIVING FACTORS

Alternative Animal Milk Oligosaccharides Are Starting To Appear, Which Will Help The Market Grow

The oligosaccharides included in cow's milk are anticipated to be crucial to baby nutrition. Infant formula made from goat milk is thought to have similar prebiotic qualities as breast milk and is anticipated to be important for a baby's digestive health, according to a laboratory study from RMIT University (Australia) that was published in the British Journal of Nutrition. Under the Kabrita brand, Ausnutria Nutrition BV (Netherlands) sells newborn formulae made with goat milk. Camel milk is another animal food source. A camel milk-based infant formula with a high iron content was introduced in 2018 by the Emirates Industry for Camel Milk and Products, popularly known as "Camelicious," a company based in the United Arab Emirates. Consequently, it is anticipated that these sources of animal milk oligosaccharides will become more popular in the markets for infant formula ingredients in the upcoming years. The manufacturing processes and the production environment are subject to strict regulatory standards in the environmental protection sector.
 
RESTRAINING FACTORS

High Cost of Human Milk Oligosaccharides to Limit Market Growth

A significant aspect that would likely impede market expansion is the high cost of manufacture. Although the end result of chemical and enzyme synthesis in the creation of HMO is minimal, it still takes a lot of time and money. High-priced substrates, including glycosyl transferases, which demand enzyme production, are one of the key causes of HMOs' high cost. Prebiotics like fructooligosaccharides and galactooligosaccharides, which promote the health of newborns' gastrointestinal tracts by encouraging the growth of specific bacteria in the microbiota of the intestine, are used in infant formula to stop pathogenic Escherichia coli from developing. They are being used by manufacturers of infant formula as an alternative to HMOs because they are inexpensive and widely accessible. These functionally equivalent alternatives to HMOs as a result significantly restrict the market's ability to grow in terms of revenue.
 
SEGMENTATION

By Type

Global Human Milk Oligosaccharides Market By Type

Based on type, the human milk oligosaccharides market is segmented into 2’FL, 3’FL, 3’SL and 6’SL. The 2’FL category dominated the market in 2022 due to its well-known ability to protect against infectious diseases and by preventing toxins and pathogens from attaching to epithelial cells, 2'-fucosyllactose (2'FL) is a commonly used substance. Three different bifidobacterial species, including B. bifidum, B. dentium, and B. infantis, are responsible for the increase in 2'FL in the intestine.
 
By Application

Based on application, the human milk oligosaccharides market is segmented into infant formula, functional food & beverage and food supplements. The infant formula category dominated the market in 2022. Increased demand for HMOs in the design of newborn formulae as a result of HMOs' advantageous properties, including their ability to prevent infections, promote the growth of the brain and intestines, and increase memory and learning. Infant formula with HMO supplements is secure, well-tolerated, and encourages development in line with age. Human milk contains structurally diverse oligosaccharides that can improve the gastrointestinal and immune systems of breastfed infants.
 
By Distribution Channel

Based on distribution channel, the human milk oligosaccharides market is segmented into hypermarkets & supermarkets, drug store or pharmacy, mass merchandiser, departmental stores, mono-brand stores, specialty stores and online sales channel. The drug store or pharmacy category dominated the market in 2022. This is explained by the fact that pharmacy owners have prioritised convenience features like extended store hours and drive-through locations in order to draw in and keep customers in the face of growing competition from online retailers and supermarkets. The convenience of purchasing at neighbourhood pharmacies or drugstores is another factor that can encourage the growth of the market. Local pharmacies are often where people go to buy prescription drugs and other medical necessities like infant formula.
 
REGIONAL INSIGHTS

 Global Human Milk Oligosaccharides Market By Region
North America is projected to hold the largest share of the human milk oligosaccharides market over the forecast period due to the existence of important industry participants and the region's technological achievements. Health benefits of HMOs are one of the major drivers boosting market growth in the area as awareness among health-conscious consumers, mostly in the U.S., develops. The region's market revenue growth is anticipated to be fueled by an increase in the number of these customers, as well as by their growing awareness of and interest in functional meals and drinks with HMO enhancements. On the other hand, the Asia Pacific human milk oligosaccharides market is anticipated to grow significantly ascribed to elements like the region's growing population, mortality rate, disposable money, and consumer awareness of health and cleanliness. Due to the growing trend of health consciousness, Chinese consumers are embracing a healthy lifestyle. Some even spend their disposable income on functional and organic food and beverages.
 
LIST OF KEY COMPANIES PROFILED:
  • Abbott Laboratories
  • BASF S.E.
  • Biosynth Carbosynth
  • Chr. Hansen Holding A/S
  • Dextra Laboratories Ltd.
  • Dupont Nutrition & Biosciences
  • Elicityl S.A.
  • Glycom A/S
  • Glycosyn
  • Inbiose NV
  • Medolac Laboratories
  • Neolacta Lifesciences Pvt. Ltd
  • Nestle Health Science
  • Royal DSM
  • ZuChem
 
Recent Development:
  • In December 2019, 2' FL was given the all-clear by Food Standards Australia New Zealand (FSANZ) for optional use in infant formula products and specially prepared supplemental foods for young children. Escherichia coli K12 production strain SCR6 that has undergone genetic modification is used to create the approved 2' FL by microbial fermentation.
REPORT SCOPE AND SEGMENTATION
 
Attributes Details
Market Size in 2022 USD 194.5 Billion
Market Forecast in 2030 USD 800.6 Billion
Compound Annual Growth Rate 22.40 %
Unit Revenue (USD Million) and Volume (Kilo Tons)
Segmentation By Type, By Application, By Distribution Channel and By Geography
By Type
  • 2’FL
  • 3’FL
  • 3’SL
  • 6’SL
By Application
  • Infant Formula
  • Functional Food & Beverage
  • Food Supplements
By Distribution Channel
  • Hypermarkets & Supermarkets
  • Drug Store or Pharmacy
  • Mass Merchandiser
  • Departmental Stores
  • Mono-brand Stores
  • Specialty Stores
  • Online Sales Channel
By Region
  • North America: U.S and Canada
  • Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
  • APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Chile
  • The Middle East And Africa: South Africa, GCC, Rest of MEA
Base Year 2022
Historical Year 2016-2021
Forecast Year 2023-2030
Chapter 1    Preface

    1.1    Report Scope and Description
        1.1.1    Study Purpose
        1.1.2    Target Audience
        1.1.3    USP and Key Offerings
    1.2    Key Benefits for Stakeholders
    1.3    Report Scope

Chapter 2    Report Summary

    2.1    Key Findings
        2.1.1    Top Investment Pockets
    2.2    Market Snapshot: Global Human Milk Oligosaccharides Market
    2.3    Global Human Milk Oligosaccharides Market, 2019 – 2030 (US$ Mn)

Chapter 3    COVID 19 Impact Analysis

    3.1    Impact Assessment of COVID-19 Pandemic, By Region
        3.1.1    North America: Impact of COVID-19 Pandemic
        3.1.2    Europe: Impact of COVID-19 Pandemic
        3.1.3    Asia pacific: Impact of COVID-19 Pandemic
        3.1.4    Latin America: Impact of COVID-19 Pandemic
        3.1.5    Middle-East and Africa: Impact of COVID-19 Pandemic
    3.2    Key Strategies Undertaken by Companies to Tackle COVID-19
    3.3    Quarterly Market Revenue by Region 2021 & 2023
    3.4    Pre COVID-19 Market Revenue, By Region, 2016-2019        (USD Million)
    3.5    Post COVID-19 Market Revenue, By Region, 2020-2030 (USD Million)
    3.6    Short Term Dynamics
    3.7    Long Term Dynamics

Chapter 4    Global Human Milk Oligosaccharides Market, By Type Segment Analysis

    4.1    Powder Compacting Pressers Market Overview, By Type Segment
        4.1.1    Global Human Milk Oligosaccharides Market Revenue Share, By Type, 2023 & 2030 (Value, %)
    4.2    2’FL
        4.2.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        4.2.2    Comparative Revenue Analysis, By Country, 2021 & 2030
        4.2.3    Key Market Trends, Growth Factors, & Opportunities
    4.3    3’FL
        4.3.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        4.3.2    Comparative Revenue Analysis, By Country, 2021 & 2030
        4.3.3    Key Market Trends, Growth Factors, & Opportunities
    4.4    3’SL
        4.4.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        4.4.2    Comparative Revenue Analysis, By Country, 2021 & 2030
        4.4.3    Key Market Trends, Growth Factors, & Opportunities
    4.5    6’SL
        4.5.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        4.5.2    Comparative Revenue Analysis, By Country, 2021 & 2030
        4.5.3    Key Market Trends, Growth Factors, & Opportunities
    
Chapter 5    Global Human Milk Oligosaccharides Market, By Distribution Channel Segment Analysis

    5.1    Powder Compacting Pressers Market Overview, By Distribution Channel Segment
        5.1.1    Global Human Milk Oligosaccharides Market Revenue Share, By Distribution Channel, 2023 & 2030 (Value, %)
    5.2    Infant Formula
        5.2.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        5.2.2    Comparative Revenue Analysis, By Country, 2023 & 2030
        5.2.3    Key Market Trends, Growth Factors, & Opportunities
    5.3    Functional Food & Beverage
        5.3.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        5.3.2    Comparative Revenue Analysis, By Country, 2023 & 2030
        5.3.3    Key Market Trends, Growth Factors, & Opportunities
    5.4    Food Supplements
        5.4.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        5.4.2    Comparative Revenue Analysis, By Country, 2023 & 2030
        5.4.3    Key Market Trends, Growth Factors, & Opportunities


Chapter 6    Global Human Milk Oligosaccharides Market, By Distribution Channel Segment Analysis

    6.1    Powder Compacting Pressers Market Overview, By Distribution Channel Segment
        6.1.1    Global Human Milk Oligosaccharides Market Value Share, By Distribution Channel, 2021 & 2030 (Value, %)
    6.2    Hypermarkets & Supermarkets
        6.2.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        6.2.2    Comparative Revenue Analysis, By Country, 2023 & 2030
        6.2.3    Key Market Trends, Growth Factors, & Opportunities
    6.3    Drug Store or Pharmacy
        6.3.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        6.3.2    Comparative Revenue Analysis, By Country, 2023 & 2030
        6.3.3    Key Market Trends, Growth Factors, & Opportunities
    6.4    Mass Merchandiser
        6.4.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        6.4.2    Comparative Revenue Analysis, By Country, 2023 & 2030
        6.4.3    Key Market Trends, Growth Factors, & Opportunities
    6.5    Departmental Stores
        6.5.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        6.5.2    Comparative Revenue Analysis, By Country, 2023 & 2030
        6.5.3    Key Market Trends, Growth Factors, & Opportunities
    6.6    Mono-brand Stores
        6.6.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        6.6.2    Comparative Revenue Analysis, By Country, 2023 & 2030
        6.6.3    Key Market Trends, Growth Factors, & Opportunities
    6.7    Specialty Stores
        6.7.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        6.7.2    Comparative Revenue Analysis, By Country, 2023 & 2030
        6.7.3    Key Market Trends, Growth Factors, & Opportunities
    6.8    Online Sales Channel
        6.8.1    Powder Compacting Pressers Share Forecast, By Region (USD Million)
        6.8.2    Comparative Revenue Analysis, By Country, 2023 & 2030
        6.8.3    Key Market Trends, Growth Factors, & Opportunities
        
Chapter 7    Powder Compacting Pressers Market – Regional Analysis, 2023 – 2030

    7.1    Powder Compacting Pressers market Overview, by Region Segment
        7.1.1    Global Human Milk Oligosaccharides market Revenue Share, By Region, 2023 & 2030
        7.1.2    Global Human Milk Oligosaccharides Market Revenue, By Region, 2017 – 2030 (US$ Mn)
        7.1.3    Global Human Milk Oligosaccharides market Revenue, By Type, 2017 – 2030 (US$ Mn)
        7.1.4    Global Human Milk Oligosaccharides market Revenue, By Distribution Channel, 2017 – 2030 (US$ Mn)
        7.1.5    Global Human Milk Oligosaccharides Market Revenue, By Distribution Channel, 2017 – 2030 (US$ Mn)
    7.2    North America
        7.2.1    North America Powder Compacting Pressers Market Revenue, By Country, 2019 – 2030 (US$ Mn)
        7.2.2    North America Powder Compacting Pressers Market Revenue, By Type, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.2.3    North America Powder Compacting Pressers Market Revenue, By Distribution Channel, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.2.4    North America Powder Compacting Pressers Market Revenue, By Distribution Channel, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.2.5    U.S. Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.2.6    Canada Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.2.7    Mexico Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
    7.3    Europe
        7.3.1    Europe Powder Compacting Pressers Market Revenue, By Country, 2019 – 2030 (US$ Mn)
        7.3.2    Europe Powder Compacting Pressers Market Revenue, By Type, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.3.3    Europe Powder Compacting Pressers Market Revenue, By Distribution Channel, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.3.4    Europe Powder Compacting Pressers Market Revenue, By Distribution Channel, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.3.5    Germany Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.3.6    France Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.3.7    U.K. Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.3.8    Italy Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.3.9    Spain Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.3.10    Rest of Europe Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
    7.4    Asia Pacific
        7.4.1    Asia Pacific Powder Compacting Pressers Market Revenue, By Country, 2019 – 2030 (US$ Mn)
        7.4.2    Asia Pacific Powder Compacting Pressers Market Revenue, By Type, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.4.3    Asia Pacific Powder Compacting Pressers Market Revenue, By Distribution Channel, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.4.4    Asia Pacific Powder Compacting Pressers Market Revenue, By Distribution Channel, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.4.5    China Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.4.6    Japan Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.4.7    India Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.4.8    South Korea Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.4.9    South-East Asia Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.4.10    Rest of Asia Pacific Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
    7.5    Latin America
        7.5.1    Latin America Powder Compacting Pressers Market Revenue, By Country, 2019 – 2030 (US$ Mn)
        7.5.2    Latin America Powder Compacting Pressers Market Revenue, By Type, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.5.3    Latin America Powder Compacting Pressers Market Revenue, By Distribution Channel, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.5.4    Latin America Powder Compacting Pressers Market Revenue, By Distribution Channel, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.5.5    Brazil Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.5.6    Argentina Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.5.7    Rest of Latin America Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
    7.6    The Middle-East and Africa
        7.6.1    The Middle-East and Africa Powder Compacting Pressers Market Revenue, By Country, 2019 – 2030 (US$ Mn)
        7.6.2    The Middle-East and Africa Powder Compacting Pressers Market Revenue, By Type, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.6.3    The Middle-East and Africa Powder Compacting Pressers Market Revenue, By Distribution Channel, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.6.4    The Middle-East and Africa Powder Compacting Pressers Market Revenue, By Distribution Channel, 2019 – 2030 (US$ Mn)/(Kilo Tons)
        7.6.5    GCC Countries Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.6.6    South Africa Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)
        7.6.7    Rest of Middle-East Africa Powder Compacting Pressers Market Revenue, 2019 - 2030 (US$ Mn)/ (Kilo Tons)

Chapter 8    Powder Compacting Pressers Market – Industry Analysis

    8.1    Introduction
    8.2    Market Drivers
        8.2.1    Driving Factor 1 Analysis
        8.2.2    Driving Factor 2 Analysis
    8.3    Market Restraints
        8.3.1    Restraining Factor Analysis
    8.4    Market Opportunities
        8.4.1    Market Opportunity Analysis
    8.5    Porter’s Five Forces Analysis
    8.6    PEST Analysis
    8.7    Regulatory Landscape
    8.8    Technology Landscape
    8.9    Value Chain Analysis

Chapter 9    Competitive Landscape

    9.1    Company Market Share Analysis – 2023
        9.1.1    Global Human Milk Oligosaccharides market: Company Market Share, 2023
        9.1.2    Global Human Milk Oligosaccharides Market: Company Market Share, 2023
    9.2    Strategic Developments
        9.2.1    Acquisitions & Mergers
        9.2.2    New Product Launch
        9.2.3    Regional Expansion
    9.3    Company Strategic Developments – Heat Map Analysis

Chapter 10    Company Profiles

    10.1    Abbott Laboratories
        10.1.1    Company Overview
        10.1.2    Key Executives
        10.1.3    Product Portfolio
        10.1.4    Financial Overview
        10.1.5    Operating Business Segments
        10.1.6    Business Segment Performance
        10.1.7    Recent Developments
    10.2    BASF S.E.
    10.3     Biosynth Carbosynth
    10.4    Chr. Hansen Holding A/S
    10.5    Dextra Laboratories Ltd.
    10.6    Dupont Nutrition & Biosciences
    10.7    Elicityl S.A.
    10.8    Glycom A/S
    10.9    Glycosyn
    10.10    Inbiose NV
    10.11    Medolac Laboratories
    10.12    Neolacta Lifesciences Pvt. Ltd
    10.13    Nestle Health Science
    10.14    Royal DSM
    10.15    ZuChem
    
Chapter 11    Research Methodology

    11.1    Research Methodology
    11.2    Phase I – Secondary Research
    11.3    Phase II - Data Modeling
        11.3.1    Company Share Analysis Model
        11.3.2    Revenue Based Modeling
    11.4    Phase III – Primary Research
    11.5    Research Limitations
        11.5.1    Assumptions
 
No Methodology
No Available